Reference
- European Central BankStatistical Data Warehouse, Exchange Rates Available from: http://sdw.ecb.europa.eu/Accessed August 11, 2014
References
- European Monitoring Centre for Drugs and Drug AddictionEuropean Drug Report 2014: Trends and DevelopmentsLuxembourgPublications Office of the European Union2014
- VolkowNDMcLellanTACurtailing diversion and abuse of opioid analgesics without jeopardizing pain treatmentJAMA201129024432454
- House of Commons Home Affairs CommitteeDrugs: New Psychoactive Substances and Prescription DrugsLondonThe Stationery Office Limited2013 Available from: http://www.publications.parliament.uk/pa/cm201314/cmselect/cmhaff/819/819.pdfAccessed August 7, 2014
- European Union (EU) CouncilEU Action Plan on Drugs 2013–2016OJEC C 351/111302013 Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:C:2013:351:0001:0023:en:PDFAccessed September 12, 2014
- RehmJPrescription Opioids and Public Health in the European UnionALICE RAP Policy Paper Series, Policy Brief 4 Available from: http://www.alicerap.eu/resources/documents/cat_view/1-alice-rap-project-documents/19-policy-paper-series.htmlAccessed August 11, 2014
- CasatiASedefovRPfeiffer-GerschelTMisuse of medicines in the European Union: a systematic review of the literatureEur Addict Res201218522824522572594
- WeisbergDFBeckerWCFiellinDAPrescription opioid misuse in the United States and the United Kingdom: cautionary lessonsInt J Drug Policy20142561124113025190034
- RiceJBKirsonNYSheiAEstimating the costs of opioid abuse and dependence from an employer perspective: a retrospective analysis using administrative claims dataAppl Health Econ Health Policy201412443544624919646
- BirnbaumHGWhiteAGSchillerMSocietal costs of prescription opioid abuse, dependence, and misuse in the United StatesPain Med201112465766721392250
- FischerBGoochJGoldmanBNon-medical prescription opioid use, prescription opioid-related harms and public health in Canada: an update 5 years laterCan J Public Health20141052e146e14924886852
- SkinnerBJNet Societal Economic Impact in Canada from Withholding Regulatory Approval for Generic Oxycontin®Canadian Health Policy9122012Toronto, ONCanadian Health Policy Institute2012
- European Monitoring Centre for Drugs and Drug AddictionStatistical Bulletin2013 Available from: http://www.emcdda.europa.eu/stats13Accessed January 15, 2014
- United Nations Office on Drugs and CrimeWorld Drug Report 2010 Available from: http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdfAccessed January 21, 2014
- DepontFHunscheEAbouelfathAMedical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in FranceFundam Clin Pharmacol201024110110819678853
- LangleyPCThe societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costsJ Med Econ20121561201121522835007
- ColomboGLCaruggiMVinciMQuality of life and treatment costs in patients with non-cancer chronic painRecenti Prog Med2004951151252015598088
- LozaELopez-GomezJMAbasoloLEconomic burden of knee and hip osteoarthritis in SpainArthritis Rheum200961215816519177521
- HongJReedCNovickDCosts associated with treatment of chronic low back pain: an analysis of the UK General Practice Research DatabaseSpine (Phila Pa 1976)2013381758223038621
- WenigCMSchmidtCOKohlmannTCosts of back pain in GermanyEur J Pain200813328028618524652
- LeardiniGSalaffiFCaporaliRDirect and indirect costs of osteoarthritis of the kneeClin Exp Rheumatol200422669970615638043
- NúñezMNúñezESegurJMHealth-related costs in patients with osteoarthritis on waiting list for total knee replacementOsteoarthritis Cartilage200715325826516962795
- BeckerAHeldHRedaelliMLow back pain in primary care: costs of care and prediction of future health care utilizationSpine (Phila Pa 1976)201035181714172021374895
- BeckerASeitzRJacobiECost evaluation by a patient questionnaire: pilot study of a weekly cost diaryRehabilitation (Stuttg)2001401122011253749
- RossiterLFKirsonNYSheiAMedical cost savings associated with an extended-release opioid with abuse-deterrent technology in the USJ Med Econ201417427928724559196
- SmithSMDartRCKatzNPClassification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsPain2013154112287229623792283
- Von KorffMRLong-term use of opioids for complex chronic painBest Pract Res Clin Rheumatol201327566367224315147
- Pain & Policy Studies GroupOpioid Consumption DataMadison, WIUniversity of Wisconsin Pain and Policy Studies Group Available from: http://www.painpolicy.wisc.edu/opioid-consumption-dataAccessed September 16, 2014
- European CommissionEurostat, Harmonised Indices of Consumer Prices (HICP) Available from: http://epp.eurostat.ec.europa.eu/portal/page/portal/hicp/data/databaseAccessed February 12, 2014
- UN DataStatistics, Population Aged 15–64 (Thousands) Available from: http://data.un.org/Data.aspx?d=PopDiv&f=variableID%3A88Accessed February 12, 2014
- Substance Abuse and Mental Health Services AdministrationResults from the 2012 National Survey on Drug Use and Health: Summary of National FindingsNSDUH Series H-46, HHS Publication No (SMA) 13-4795Rockville, MDSubstance Abuse and Mental Health Services Administration2013
- Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and QualityTreatment Episode Data Set (TEDS): 2001–2011. National Admissions to Substance Abuse Treatment ServicesBHSIS Series S-65, HHS Publication No (SMA) 13–4772Rockville, MDSubstance Abuse and Mental Health Services Administration2013
- ZinCSChenLCKnaggsRDChanges in trends and pattern of strong opioid prescribing in primary careEur J Pain20141891343135124756859
- European Monitoring Centre for Drugs and Drug AddictionStatistical Bulletin2006 Available from: http://stats06.emcdda.europa.eu/en/home-en.htmlAccessed September 17, 2014
- Substance Abuse and Mental Health Services AdministrationResults from the 2002 National Survey on Drug Use and Health: National FindingsNHSDA Series H-22, DHHS Publication No SMA03-3836Rockville, MDSubstance Abuse and Mental Health Services Administration2003
- SesslerNEDowningJMHrishikeshKReductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulationPharmacoepidemiol Drug Saf201423121238124624916486
- DePriestAZMillerKOxycodone/naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrencePain Ther20143111525135384
- TarginiqERPrescribing InformationStamford, CTPurdue Pharma LP Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205777lbl.pdfAccessed October 6, 2014
- European Central BankStatistical Data Warehouse, Exchange Rates Available from: http://sdw.ecb.europa.eu/Accessed August 11, 2014
- United Nations Office on Drugs and CrimeWorld Drug Report 2013 Available from: http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013pdfAccessed May 7, 2015
- United Nations Office on Drugs and CrimeWorld Drug Report 2014 Available from: http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdfAccessed May 7, 2015